Cardiovascular outcome 6 months after severe coronavirus disease 2019 infection. Issue 7 (25th July 2022)

• Record Type: Journal Article
• Authors: Raafs, Anne G.; Ghossein, Mohammed A.; Brandt, Yentl; Henkens, Michiel T.H.M.; Kooi, M. Eline; Vernooy, Kevin; Spaanderman, Marc E.A.; Gerretsen, Suzanne; van Santen, Susanne; Driessen, Rob G.H.; Knackstedt, Christian; van der Horst, Iwan C.C.; van Bussel, Bas C.T.; Heymans, Stephane R.B.; Ghossein-Doha, Chahinda
• Other Names: collaborator.
• Is Part Of: Journal of hypertension. Volume 40:Issue 7(2022)
• Page Start: 1278
• Page End: 1287
• Publication Date: 2022-07-25
• Subjects: cardiac injury -- cardiac MRI -- coronavirus disease 2019 -- echocardiography -- electrocardiography; Hypertension -- Periodicals; Hypertension -- Periodicals; 616.132005
• DOI: 10.1097/HJH.0000000000003110
• Languages: English
• ISSNs: 1473-5598

Abstract

Abstract : Objectives: In coronavirus disease 2019 (COVID-19), cardiovascular risk factors and myocardial injury relate to increased mortality. We evaluated the extent of cardiac sequelae 6 months after hospital discharge in patients surviving ICU hospitalization for COVID-19. Methods: All survivors of Maastricht-ICU were invited for comprehensive cardiovascular evaluation 6 months after discharge from ICU. Cardiac screening included an electrocardiogram, cardiac biomarkers, echocardiography, cardiac magnetic resonance (CMR) and, wherever indicated, cardiac computed tomography or coronary angiogram. Results: Out of 52 survivors, 81% ( n = 42) participated to the cardiovascular follow-up [median follow-up of 6 months, interquartile range (IQR) 6.1–6.7]. Eight patients (19%) had newly diagnosed coronary artery disease (CAD), of which two required a percutaneous intervention. Echocardiographic global longitudinal strain (GLS) was abnormal in 24% and CMR-derived GLS was abnormal in 12%, despite normal left ventricular ejection fraction in all. None of the patients showed elevated T1 relaxation times and five patients (14%) had an elevated T2 relaxation time. Late gadolinium enhancement (LGE) reflecting regional myocardial fibrosis was increased in eight patients (21%), of which three had myocarditis and three had pericarditis. Conclusion: Cardiovascular follow-up at 6 months after ICU-admission for severe COVID-19 revealed that one out of five invasively mechanically ventilated survivors had CAD, a quarter had subclinical left ventricular dysfunction defined as reduced echocardiographic GLS, and 42% of the patients had CMR abnormalities (reduced LVEF, reduced GLS, LGE presence, and elevated T2 ). On the basis of these findings, long-term cardiovascular follow-up is strongly recommended in all post-IC COVID-19 patients. Clinical Trial Registration: Trial Register number [NL8613]) https://www.trialregister.nl/trial/8613 Video abstract: http://links.lww.com/HJH/B899 .